Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antib... - PubMed - NCBI

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antib... - PubMed - NCBI

J Oncol Pract. 2016 Feb;12(2):180-1. doi: 10.1200/JOP.2015.007898. Epub 2015 Oct 6.

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.

Allegra CJ1, Rumble RB1, Schilsky RL1.

Author information

PMID:

 

26443838

 

DOI:

 

10.1200/JOP.2015.007898

[PubMed - indexed for MEDLINE]